SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BofA Securities Lowers Arcus Biosciences Price Target to $28 From $29

BofA Securities lowered its price target on Arcus Biosciences to $28 from $29.

RCUS

Related stories